In June 2009, the Study Group on Peripartum Cardiomyopathy was formed by the Heart Failure Association of the European Society of Cardiology. This Study Group consists of experts from cardiology, basic sciences, intensive care, obstetrics and gynecology, imaging, genetics and other disciplines.
We feel that such a group can promote ongoing interest and research into this disease of unknown etiology and facilitate lessons to be learned relevant to other conditions. Spread the word and create a network by putting up this Information Flyer.
The primary objective of this world-wide registry on PPCM is to establish the clinical epidemiology and the diagnostic/therapeutic processes of women suffering from that condition as well as collecting information of their off-springs.
To receive information on how to participate in this registry, please contact the EURObservational Research Programme via the contact form.
Participating centres will be able to receive newsletters and could consider participating in related PPCM companion studies on genetics, biomarkers and device therapy.
Peripartum cardiomyopathy: current management and future perspectives: European Heart Journal
Prof. J. Bauersachs FESC (Hannover, DE) email
Prof. K. Sliwa-Hahnle FESC (Cape Town, South Africa)
D Hilfiker-Kleiner (Hannover, DE)
A Mebazaa (Paris, FR)
F Mouquet (Lille, FR)
M Petrie (Glasgow, GB)
V Regitz-Zagrosek (Berlin, DE)
M Schaufelberger (Gothenburg, SE)
P Seferovic (Belgrade, RS)
E Kraigher-Krainer (Graz, AT)
K van Spaendonck-Zwarts (Groningen, NL)
P van der Meer (Groningen, NL)
U Elkayam (Los Angeles, US)
K Bachelier (Homburg/Saar, DE)
A Mbakwem (Lagos, NG)
J McMurray (Glasgow, GB)
A Shah (London, GB)
L Tavazzi (Cotignola, IT)
D van Veldhuisen (Gronongen, NL)
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved